Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zackery P Bulman

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
International Journal of Antimicrobial Agents|September 27, 2025
Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteriaBrooke N Curry, Nidhi Singh, Alan E Gross, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2017
New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniaeZackery P Bulman, Michael J Satlin, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2017
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniaeMiao Zhao, Zackery P Bulman, Justin R Lenhard, et al.
Mbio|July 27, 2017
Polymyxin Combinations Combat <i>Escherichia coli</i> Harboring <i>mcr-1</i> and <i>bla</i><sub>NDM-5</sub>: Preparation for a Postantibiotic EraZackery P Bulman, Liang Chen, Thomas J Walsh, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2021
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Karol Sokolowski, Amisha Rana, et al.
Frontiers in Pharmacology|August 16, 2024
Interaction of <i>Acinetobacter</i> sp. RIT 592 induces the production of broad-spectrum antibiotics in <i>Exiguobacterium</i> sp. RIT 594Anutthaman Parthasarathy, Renata Rezende Miranda, T J Bedore, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection modelNidhi Singh, Christin M L Jogan, Yanan Zang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
International Journal of Antimicrobial Agents|September 27, 2025
Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteriaBrooke N Curry, Nidhi Singh, Alan E Gross, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2017
New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniaeZackery P Bulman, Michael J Satlin, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2017
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniaeMiao Zhao, Zackery P Bulman, Justin R Lenhard, et al.
Mbio|July 27, 2017
Polymyxin Combinations Combat <i>Escherichia coli</i> Harboring <i>mcr-1</i> and <i>bla</i><sub>NDM-5</sub>: Preparation for a Postantibiotic EraZackery P Bulman, Liang Chen, Thomas J Walsh, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2021
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Karol Sokolowski, Amisha Rana, et al.
Frontiers in Pharmacology|August 16, 2024
Interaction of <i>Acinetobacter</i> sp. RIT 592 induces the production of broad-spectrum antibiotics in <i>Exiguobacterium</i> sp. RIT 594Anutthaman Parthasarathy, Renata Rezende Miranda, T J Bedore, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection modelNidhi Singh, Christin M L Jogan, Yanan Zang, et al.
Pageof 6